Advanced Oncotherapy (AVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 Feb 2024 05:19 PM
RNS
Further update on financing discussions
01 Feb 2024 07:00 AM
RNS
Further update on financing discussions
09 Jan 2024 09:00 AM
RNS
Update on Financing Discussions
23 Oct 2023 07:00 AM
RNS
Update on Financing and Current Financial Position
29 Sep 2023 04:04 PM
RNS
Update on Financial Results
17 Jul 2023 07:00 AM
RNS
Recapitalisation and funding plan, update on FSP
30 Jun 2023 05:00 PM
RNS
Total Voting Rights
30 Jun 2023 07:15 AM
RNS
Update on financing, suspension of trading on AIM
29 Jun 2023 01:35 PM
RNS
Holding(s) in Company
26 Jun 2023 10:57 AM
RNS
Partial conversion of Convertible Notes
23 Jun 2023 11:05 AM
RNS
Holding(s) in Company
20 Jun 2023 05:28 PM
RNS
Holding(s) in Company
19 Jun 2023 05:56 PM
RNS
Partial conversion of Convertible Notes
16 Jun 2023 06:23 PM
RNS
Issue of warrants
31 May 2023 05:57 PM
RNS
Update on financing and convertible notes
24 May 2023 05:54 PM
RNS
Form 8 (OPD) Advanced Oncotherapy plc
24 May 2023 05:29 PM
RNS
Form 8.3 - Advanced Oncotherapy - Cosylab d.d.
15 May 2023 11:36 AM
RNS
Update on Convertible Note & Loan Extension
15 May 2023 11:36 AM
RNS
Update on Convertible Note & Loan Extension
12 May 2023 12:53 PM
RNS
Form 8.3 - Advanced Oncotherapy - Minmetco Limited
11 May 2023 05:14 PM
RNS
Form 8.3 - Advanced Oncotherapy - eQ Blue Planet
11 May 2023 11:17 AM
RNS
Form 8.3 - Advanced Oncotherapy - Atlantic Cedar
09 May 2023 04:40 PM
RNS
Form 8.3 - Advanced Oncotherapy - Baltisches Haus
05 May 2023 07:00 AM
RNS
Additional funding from Secured Convertible Note
04 May 2023 03:55 PM
RNS
Change of Registered Office
03 May 2023 06:19 PM
RNS
Rule 2.9 Announcement
02 May 2023 06:19 PM
RNS
Form 8 (OPD) Advanced Oncotherapy plc
18 Apr 2023 07:00 AM
RNS
Strategic review and formal sale process
31 Mar 2023 06:05 PM
RNS
Holding(s) in Company
20 Mar 2023 12:36 PM
RNS
Update on Secured Convertible Note Facility
01 Mar 2023 02:54 PM
RNS
Secured Convertible Note Facility & other matters
01 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
01 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
27 Jan 2023 04:53 PM
EQS
Hardman & Co Research: Q&A on Advanced ...
18 Jan 2023 02:00 PM
RNS
Operational update
17 Jan 2023 03:10 PM
EQS
Hardman & Co Research on Advanced Oncothera...
30 Dec 2022 01:00 PM
RNS
Total Voting Rights
30 Dec 2022 09:24 AM
RNS
Director/PDMR Shareholding
29 Dec 2022 03:12 PM
RNS
Director/PDMR Shareholding
28 Dec 2022 07:00 AM
RNS
Director/PDMR Shareholding
23 Dec 2022 12:40 PM
RNS
Second Price Monitoring Extn
23 Dec 2022 12:35 PM
RNS
Price Monitoring Extension
12 Dec 2022 07:00 AM
RNS
Equity Subscription and Issue of Warrants
01 Dec 2022 07:00 AM
RNS
Issue of Equity
28 Nov 2022 07:00 AM
RNS
Study showcases the potential superiority of LIGHT
03 Nov 2022 03:20 PM
RNS
Investor / Analyst Event Update
31 Oct 2022 05:00 PM
RNS
Total Voting Rights
27 Oct 2022 07:31 AM
RNS
Presentation highlights superiority of LIGHT
21 Oct 2022 07:00 AM
RNS
Notice of Investor / Analyst Event
18 Oct 2022 07:00 AM
RNS
Equity Subscription and Issue of Warrants
UK 100